VMPL
Bengaluru (Karnataka) [India], August 26: Sugarfit, India's evidence-led metabolic health platform, today announced the publication of findings from its multicentre randomized controlled trial (RCT) in Frontiers in Endocrinology. The study found that participants using Sugarfit's structured metabolic care program achieved an average 1.46% reduction in HbA1c over 90 days, compared with a 0.07% increase among participants receiving standard care alone (p
Sugarfit RCT Shows Significant HbA1c and Weight Reduction in 90 Days, and GLP-1 Care Scales to 12,000 Users
